Ronald W. Davis, PhD, a pre-eminent scientist at Stanford and our own scientific advisory board director, in this interview mentions 4 prospective biomarkers, tells of the OMF-funded research now being pursued, and tells of the biological abnormalities being seen in ME / CFS patients. He also gives some advice for healthcare providers.
The interviewer is Deborah Becker with WBUR.
Transcript: Dr Ron Davis MA Dept Public Health April 2018